Top compounds associated with response to ACTBL2


Feature Type Standardized
Nominal ANOVA
mRNA PD-0325901 gCSI pan-cancer AAC 0.15 0.01
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.01
mRNA BRD-K75293299 CTRPv2 pan-cancer AAC 0.19 0.01
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC 0.081 0.02
mRNA KU-60019 CTRPv2 pan-cancer AAC 0.084 0.02
mRNA Dasatinib CTRPv2 pan-cancer AAC 0.087 0.02
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.02
mRNA procarbazine CTRPv2 pan-cancer AAC 0.093 0.02
mRNA BRD-K35604418 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA Platin CTRPv2 pan-cancer AAC 0.087 0.02
Download CSV